Cite
PREVALENCE AND FACTORS ASSOCIATED WITH NAFLD IN PEOPLE WITH HIV.
MLA
van Eekeren, Louise E., et al. “Prevalence and Factors Associated with Nafld in People with Hiv.” Topics in Antiviral Medicine, vol. 31, no. 2, Apr. 2023, pp. 240–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303856&authtype=sso&custid=ns315887.
APA
van Eekeren, L. E., Blaauw, M. J. T., Vadaq, N., Matzaraki, V., Vos, W. A. J. W., Groenendijk, A. L., Navas, A., Weijers, G., van Der Kolk, M., van Der Ven, A. J. A. M., De Mast, Q., Joosten, L., & Tjwa, E. (2023). Prevalence and Factors Associated with Nafld in People with Hiv. Topics in Antiviral Medicine, 31(2), 240–241.
Chicago
van Eekeren, Louise E., Marc J. T. Blaauw, Nadira Vadaq, Vasiliki Matzaraki, Wilhelm A. J. W. Vos, Albert L. Groenendijk, Adriana Navas, et al. 2023. “Prevalence and Factors Associated with Nafld in People with Hiv.” Topics in Antiviral Medicine 31 (2): 240–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303856&authtype=sso&custid=ns315887.